Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;25(6):1046-1058.
doi: 10.1038/s41590-024-01843-8. Epub 2024 May 30.

Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement

Xin Lan  1   2 , Tian Mi  1 , Shanta Alli  1 , Cliff Guy  1 , Mohamed Nadhir Djekidel  3 , Xueyan Liu  4 , Shannon Boi  1 , Partha Chowdhury  1 , Minghong He  1 , Dietmar Zehn  5 , Yongqiang Feng  1 , Ben Youngblood  6
Affiliations

Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement

Xin Lan et al. Nat Immunol. 2024 Jun.

Abstract

The durability of an antitumor immune response is mediated in part by the persistence of progenitor exhausted CD8+ T cells (Tpex). Tpex serve as a resource for replenishing effector T cells and preserve their quantity through self-renewal. However, it is unknown how T cell receptor (TCR) engagement affects the self-renewal capacity of Tpex in settings of continued antigen exposure. Here we use a Lewis lung carcinoma model that elicits either optimal or attenuated TCR signaling in CD8+ T cells to show that formation of Tpex in tumor-draining lymph nodes and their intratumoral persistence is dependent on optimal TCR engagement. Notably, attenuated TCR stimulation accelerates the terminal differentiation of optimally primed Tpex. This TCR-reinforced Tpex development and self-renewal is coupled to proximal positioning to dendritic cells and epigenetic imprinting involving increased chromatin accessibility at Egr2 and Tcf1 target loci. Collectively, this study highlights the critical function of TCR engagement in sustaining Tpex during tumor progression.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577–581 (2014). - PubMed - PMC - DOI
    1. Philip, M. & Schietinger, A. CD8+ T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 22, 209–223 (2022). - PubMed - DOI
    1. Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550–4557 (2011). - PubMed - PMC - DOI
    1. Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015). - PubMed - PMC - DOI
    1. Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758–761 (1993). - PubMed - DOI

MeSH terms

Substances

LinkOut - more resources

-